Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on … – GlobeNewswire (press release)
|
Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on …
GlobeNewswire (press release) SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology … |
